schliessen

Filtern

 

Bibliotheken

Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters

Lung cancer is one of the leading causes of cancer-associated mortality. C-reactive protein (CRP), albumin (ALB), globulin (GLB), lactate dehydrogenase (LDH), neutrophil-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been identified as general parameters for systemic inflammatory... Full description

Journal Title: Oncology letters February 2019, Vol.17(2), pp.2244-2256
Main Author: Zhu, Jie
Other Authors: Lian, Lian , Qin, Hualong , Wang, Wen-Jie , Ren, Rui , Xu, Meng-Dan , Chen, Kai , Duan, Weiming , Gong, Fei-Ran , Tao, Min , Zhi, Qiaoming , Wu, Meng-Yao , Li, Wei
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 1792-1074 ; PMID: 30675290 Version:1 ; DOI: 10.3892/ol.2018.9858
Link: http://pubmed.gov/30675290
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline30675290
title: Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters
format: Article
creator:
  • Zhu, Jie
  • Lian, Lian
  • Qin, Hualong
  • Wang, Wen-Jie
  • Ren, Rui
  • Xu, Meng-Dan
  • Chen, Kai
  • Duan, Weiming
  • Gong, Fei-Ran
  • Tao, Min
  • Zhi, Qiaoming
  • Wu, Meng-Yao
  • Li, Wei
subjects:
  • Lung Cancer
  • Prognosis
  • Systemic Inflammatory Response
ispartof: Oncology letters, February 2019, Vol.17(2), pp.2244-2256
description: Lung cancer is one of the leading causes of cancer-associated mortality. C-reactive protein (CRP), albumin (ALB), globulin (GLB), lactate dehydrogenase (LDH), neutrophil-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been identified as general parameters for systemic inflammatory response (SIR). Furthermore, these parameters are also associated with tumor development and metastasis. The present study aimed to investigate the predictive values of these SIR parameters in patients with resectable lung cancer. In total, 101 patients with resectable lung cancer were recruited in the present study. The patients were divided into two groups according to the median value of pre-treatment CRP, ALB, GLB, LDH, NLR or PLR values. The post-/pre-treatment ratios were defined as the ratio of pre-treatment blood parameter values and the corresponding values obtained following therapy. A ratio of ≤1.1 indicated that the values were not increased, while a ratio of >1.1 suggested that...
language: eng
source:
identifier: ISSN: 1792-1074 ; PMID: 30675290 Version:1 ; DOI: 10.3892/ol.2018.9858
fulltext: fulltext
issn:
  • 17921074
  • 1792-1074
url: Link


@attributes
ID1112724486
RANK0.06999999
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid30675290
sourceidmedline
recordidTN_medline30675290
sourceformatXML
sourcesystemPC
pqid2174143058
galeid574315133
display
typearticle
titlePrognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters
creatorZhu, Jie ; Lian, Lian ; Qin, Hualong ; Wang, Wen-Jie ; Ren, Rui ; Xu, Meng-Dan ; Chen, Kai ; Duan, Weiming ; Gong, Fei-Ran ; Tao, Min ; Zhi, Qiaoming ; Wu, Meng-Yao ; Li, Wei
ispartofOncology letters, February 2019, Vol.17(2), pp.2244-2256
identifier
subjectLung Cancer ; Prognosis ; Systemic Inflammatory Response
descriptionLung cancer is one of the leading causes of cancer-associated mortality. C-reactive protein (CRP), albumin (ALB), globulin (GLB), lactate dehydrogenase (LDH), neutrophil-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been identified as general parameters for systemic inflammatory response (SIR). Furthermore, these parameters are also associated with tumor development and metastasis. The present study aimed to investigate the predictive values of these SIR parameters in patients with resectable lung cancer. In total, 101 patients with resectable lung cancer were recruited in the present study. The patients were divided into two groups according to the median value of pre-treatment CRP, ALB, GLB, LDH, NLR or PLR values. The post-/pre-treatment ratios were defined as the ratio of pre-treatment blood parameter values and the corresponding values obtained following therapy. A ratio of ≤1.1 indicated that the values were not increased, while a ratio of >1.1 suggested that...
languageeng
source
version7
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/30675290$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontrib
0Zhu, Jie
1Lian, Lian
2Qin, Hualong
3Wang, Wen-Jie
4Ren, Rui
5Xu, Meng-Dan
6Chen, Kai
7Duan, Weiming
8Gong, Fei-Ran
9Tao, Min
10Zhi, Qiaoming
11Wu, Meng-Yao
12Li, Wei
titlePrognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters
descriptionLung cancer is one of the leading causes of cancer-associated mortality. C-reactive protein (CRP), albumin (ALB), globulin (GLB), lactate dehydrogenase (LDH), neutrophil-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been identified as general parameters for systemic inflammatory response (SIR). Furthermore, these parameters are also associated with tumor development and metastasis. The present study aimed to investigate the predictive values of these SIR parameters in patients with resectable lung cancer. In total, 101 patients with resectable lung cancer were recruited in the present study. The patients were divided into two groups according to the median value of pre-treatment CRP, ALB, GLB, LDH, NLR or PLR values. The post-/pre-treatment ratios were defined as the ratio of pre-treatment blood parameter values and the corresponding values obtained following therapy. A ratio of ≤1.1 indicated that the values were not increased, while a ratio of >1.1 suggested that...
subject
0Lung Cancer
1Prognosis
2Systemic Inflammatory Response
general
030675290
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
310.3892/ol.2018.9858
4MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline30675290
issn
017921074
11792-1074
rsrctypearticle
creationdate2019
addtitleOncology letters
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr41201902
citationpf 2244 vol 17 issue 2
startdate20190201
enddate20190231
lsr30VSR-Enriched:[eissn, pqid, galeid]
sort
titlePrognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters
authorZhu, Jie ; Lian, Lian ; Qin, Hualong ; Wang, Wen-Jie ; Ren, Rui ; Xu, Meng-Dan ; Chen, Kai ; Duan, Weiming ; Gong, Fei-Ran ; Tao, Min ; Zhi, Qiaoming ; Wu, Meng-Yao ; Li, Wei
creationdate20190200
lso0120190200
facets
frbrgroupid9066222777245060182
frbrtype5
newrecords20190702
languageeng
creationdate2019
topic
0Lung Cancer
1Prognosis
2Systemic Inflammatory Response
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontrib
0Zhu, Jie
1Lian, Lian
2Qin, Hualong
3Wang, Wen-Jie
4Ren, Rui
5Xu, Meng-Dan
6Chen, Kai
7Duan, Weiming
8Gong, Fei-Ran
9Tao, Min
10Zhi, Qiaoming
11Wu, Meng-Yao
12Li, Wei
jtitleOncology Letters
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Zhu
1Lian
2Qin
3Wang
4Ren
5Xu
6Chen
7Duan
8Gong
9Tao
10Zhi
11Wu
12Li
aufirst
0Jie
1Lian
2Hualong
3Wen-Jie
4Rui
5Meng-Dan
6Kai
7Weiming
8Fei-Ran
9Min
10Qiaoming
11Meng-Yao
12Wei
au
0Zhu, Jie
1Lian, Lian
2Qin, Hualong
3Wang, Wen-Jie
4Ren, Rui
5Xu, Meng-Dan
6Chen, Kai
7Duan, Weiming
8Gong, Fei-Ran
9Tao, Min
10Zhi, Qiaoming
11Wu, Meng-Yao
12Li, Wei
atitlePrognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters
jtitleOncology letters
risdate201902
volume17
issue2
spage2244
pages2244-2256
issn1792-1074
formatjournal
genrearticle
ristypeJOUR
abstractLung cancer is one of the leading causes of cancer-associated mortality. C-reactive protein (CRP), albumin (ALB), globulin (GLB), lactate dehydrogenase (LDH), neutrophil-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been identified as general parameters for systemic inflammatory response (SIR). Furthermore, these parameters are also associated with tumor development and metastasis. The present study aimed to investigate the predictive values of these SIR parameters in patients with resectable lung cancer. In total, 101 patients with resectable lung cancer were recruited in the present study. The patients were divided into two groups according to the median value of pre-treatment CRP, ALB, GLB, LDH, NLR or PLR values. The post-/pre-treatment ratios were defined as the ratio of pre-treatment blood parameter values and the corresponding values obtained following therapy. A ratio of ≤1.1 indicated that the values were not increased, while a ratio of >1.1 suggested that...
doi10.3892/ol.2018.9858
pmid30675290
eissn17921082
date2019-02